PBYI - Puma Biotechnology Non-GAAP EPS of $0.28 revenue of $59.5M
- Puma Biotechnology press release ( NASDAQ: PBYI ): Q2 Non-GAAP EPS of $0.28.
- Revenue of $59.5M (+11.4% Y/Y).
- At June 30, 2022, Puma had cash, cash equivalents and marketable securities of $60.8M, compared to cash, cash equivalents and marketable securities of $82.1M at December 31, 2021.
For further details see:
Puma Biotechnology Non-GAAP EPS of $0.28, revenue of $59.5M